Bellobuono A - Search Results

1

Molecular epidemiology of hepatitis C virus infection among intravenous drug users.

Silini E, Bono F, Cividini A, Cerino A, Maccabruni A, Tinelli C, Bruno S, Bellobuono A, Mondelli M. Silini E, et al. Among authors: bellobuono a. J Hepatol. 1995 Jun;22(6):691-5. doi: 10.1016/0168-8278(95)80225-8. J Hepatol. 1995. PMID: 7560863

2

Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.

Bellobuono A, Mondazzi L, Tempini S, Silini E, Idéo G. Bellobuono A, et al. Eur J Gastroenterol Hepatol. 1997 Dec;9(12):1169-77. Eur J Gastroenterol Hepatol. 1997. PMID: 9471022 Clinical Trial.

3

Alpha interferon treatment in chronic hepatitis C.

Idéo G, Bellobuono A, Mondazzi L, Tempini S, Bellati G, Idéo GM, Silini E. Idéo G, et al. Among authors: bellobuono a. Clin Exp Rheumatol. 1995 Nov-Dec;13 Suppl 13:S167-73. Clin Exp Rheumatol. 1995. PMID: 8730501 Clinical Trial.

4

Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial.

Bellobuono A, Mondazzi L, Tempini S, Silini E, Vicari F, Idéo G. Bellobuono A, et al. J Viral Hepat. 1997 May;4(3):185-91. doi: 10.1046/j.1365-2893.1997.00142.x. J Viral Hepat. 1997. PMID: 9181527 Clinical Trial.

5

Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?

Bellobuono A, Mondazzi L, Tempini S, Chiodo F, Magliano E, Mondini C, Idéo G. Bellobuono A, et al. J Hepatol. 1999 Jan;30(1):8-13. doi: 10.1016/s0168-8278(99)80002-6. J Hepatol. 1999. PMID: 9927145 Clinical Trial.

6

Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy.

Bellobuono A, Mondazzi L, Tempini S, Chiodo F, Magliano E, Furione L, Idéo G. Bellobuono A, et al. J Hepatol. 2000 Sep;33(3):463-8. doi: 10.1016/s0168-8278(00)80283-4. J Hepatol. 2000. PMID: 11020003 Clinical Trial.

7

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.

Schalm SW, Hansen BE, Chemello L, Bellobuono A, Brouwer JT, Weiland O, Cavalletto L, Schvarcz R, Ideo G, Alberti A. Schalm SW, et al. Among authors: bellobuono a. J Hepatol. 1997 May;26(5):961-6. doi: 10.1016/s0168-8278(97)80103-1. J Hepatol. 1997. PMID: 9186825

8

Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre study.

Idéo G, Bellobuono A, Tempini S, Mondazzi L, Airoldi A, Benetti G, Bissoli F, Cestari C, Colombo E, Del Poggio P, Fracassetti O, Lazzaroni S, Marelli A, Paris B, Prada A, Rainer E, Roffi L. Idéo G, et al. Among authors: bellobuono a. Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1203-7. doi: 10.1097/00042737-199911000-00003. Eur J Gastroenterol Hepatol. 1999. PMID: 10563527 Clinical Trial.

9

Prevalence of hepatitis C virus antibodies in Italian blood donors. The Italian Cooperative Group.

Sirchia G, Almini D, Bellobuono A, Giovanetti AM, Marconi M, Mercuriali F, Mozzi F, Parravicini A, Pizzi M, Zanuso F. Sirchia G, et al. Among authors: bellobuono a. Vox Sang. 1990;59(1):26-9. doi: 10.1111/j.1423-0410.1990.tb02109.x. Vox Sang. 1990. PMID: 2118697 Clinical Trial.

10

New therapies for the treatment of chronic hepatitis C.

Idéo G, Bellobuono A. Idéo G, et al. Among authors: bellobuono a. Curr Pharm Des. 2002;8(11):959-66. doi: 10.2174/1381612024607009. Curr Pharm Des. 2002. PMID: 11945142 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters